Medicinal Chemistry Approaches for Multitarget Drugs
Authors:
- 15 September 2010
- book chapter
- Published by Wiley
- p. 249-274
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agentProceedings of the National Academy of Sciences, 2009
- Therapeutic potential of novel selective-spectrum kinase inhibitors in oncologyExpert Opinion on Investigational Drugs, 2008
- Multicomponent therapeutics for networked systemsNature Reviews Drug Discovery, 2005
- A Bivalent Ligand (KDAN-18) Containing δ-Antagonist and κ-Agonist Pharmacophores Bridges δ2 and κ1 Opioid Receptor PhenotypesJournal of Medicinal Chemistry, 2004
- Cardiovascular combinationsNature Reviews Drug Discovery, 2004
- Discovery of 5-[5-Fluoro-2-oxo-1,2- dihydroindol-(3Z)-ylidenemethyl]-2,4- dimethyl-1H-pyrrole-3-carboxylic Acid (2-Diethylaminoethyl)amide, a Novel Tyrosine Kinase Inhibitor Targeting Vascular Endothelial and Platelet-Derived Growth Factor Receptor Tyrosine KinaseJournal of Medicinal Chemistry, 2003
- Discovery of N-Isoxazolyl Biphenylsulfonamides as Potent Dual Angiotensin II and Endothelin A Receptor AntagonistsJournal of Medicinal Chemistry, 2002
- Parallel synthesis of 3-aryloxy-2-propanolamines and evaluation as dual affinity 5-HT1A and 5-HT re-uptake ligandsBioorganic & Medicinal Chemistry Letters, 1999
- Dual D2-Receptor and β2-Adrenoceptor Agonists for the Treatment of Airway Diseases. 1. Discovery and Biological Evaluation of Some 7-(2-Aminoethyl)- 4-hydroxybenzothiazol-2(3H)-one AnaloguesJournal of Medicinal Chemistry, 1998
- Dibenz[b,e]oxepin derivatives: novel antiallergic agents possessing thromboxane A2 and histamine H1 dual antagonizing activity. 1Journal of Medicinal Chemistry, 1993